(-)-epigallocatechin 3-gallateFinding
(-)-epigallocatechin 3-gallate inhibits EGFR
lowersInsufficient evidenceFinding
01 · The sentence it was drawn from
“EGCG also suppressed EGFR expression, especially in Hep3BLR.”
(-)-epigallocatechin 3-gallate
EGFR
inhibits
- Who
- Hep3B human hepatocellular carcinoma cells and the lenvatinib-resistant Hep3BLR subline
- Dose studied
- 10 μg/ml
Insufficient evidencePMID 41006034 · 2025
02 · The study
- Study
- in vitro · not in humans
- Duration
- not reported
Evidence, by strength
- strong
- moderate
- limited
- very limited
- insufficientthis finding
03 · The paper
Anticancer research04 · To cite this finding
This address does not changehttps://catalystproject.ai/e/01M3J952K7ZA0HWZ0GWP31FAPQ